Seeking Alpha

Shares of Theravence (THRX -33.4%) crater after the firm's Phase III results for Relovair...

Shares of Theravence (THRX -33.4%) crater after the firm's Phase III results for Relovair (previous) includes the disclosure of pneumonia-related deaths in patients.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|